National Eye Institute and TRICARE Vision Benefits
*TRICARE.com is an independent reference site and is not the official TRICARE program. For official policy and the most current government information, visit TRICARE.mil.*
## Quick answer The National Eye Institute (NEI) is a federal research agency that does not provide TRICARE insurance coverage or direct clinical care to beneficiaries. Instead, TRICARE relies on NEI research and clinical trials to determine which vision treatments, such as LASIK or advanced glaucoma therapies, meet the "proven" standard required for official coverage.
In detail
The National Eye Institute (NEI) is part of the National Institutes of Health (NIH). While it doesn't process claims or issue referrals for TRICARE members, it plays a critical role in the military health ecosystem in two primary ways:
### 1. Defining "Proven" Treatments TRICARE policy generally prohibits coverage for "experimental or unproven" treatments. When the Defense Health Agency (DHA) evaluates whether to add a new vision procedure to the TRICARE benefit, they heavily weigh clinical trial data and peer-reviewed studies funded or conducted by the NEI. This includes research on: * Age-related macular degeneration (AMD) * Diabetic retinopathy * Glaucoma management * Gene therapy for inherited retinal diseases
### 2. Clinical Trials at the NIH Clinical Center While TRICARE does not usually cover the costs of experimental treatments, beneficiaries with rare or life-threatening eye conditions may be eligible to participate in NEI-conducted clinical trials at the NIH Clinical Center in Bethesda, Maryland. * **Cost for Participants:** If accepted into an NEI intramural trial, the medical care provided at the NIH is generally free of charge to the participant. * **TRICARE Authorization:** Enrollment in a clinical trial often requires coordination through your regional contractor (**Humana Military** in the East or **TriWest Healthcare Alliance** in the West) to ensure that routine "standard of care" costs are still covered by TRICARE.
### TRICARE Vision Coverage vs. NEI Research While the NEI researches high-level cures, TRICARE’s actual vision benefits are managed based on your plan and beneficiary status.
| Benefit Type | TRICARE Prime/Select Rules (2026) | Role of NEI | | :--- | :--- | :--- | | **Routine Eye Exams** | Covered for Active Duty (yearly) and Retirees (every 2 years). | Sets the clinical standards for what an exam should include. | | **Medically Necessary Care** | Covered for all if treating a disease (e.g., cataracts). | Researches the surgical techniques used. | | **Corrective Lenses** | Generally not covered for retirees unless following surgery. | Researches lens technologies. | | **Refractive Surgery** | Limited to Active Duty via military facilities. | Defines safety thresholds for laser technology. |
## Who this applies to * **Active Duty Service Members (ADSMs):** May seek NEI-funded clinical trials for trauma-related vision loss or experimental treatments not yet available in MTFs. * **Active Duty Family Members (ADFMs):** Rely on TRICARE’s adoption of NEI-validated treatments for chronic conditions like pediatric strabismus. * **Retirees and Families:** Particularly those with age-related conditions (Glaucoma, AMD) where NEI research frequently leads to new TRICARE-covered drug therapies. * **Beneficiaries with Rare Eye Diseases:** May use the NEI search tools to find clinical trials when standard TRICARE treatments have failed.
Common scenarios
### Scenario 1: Participation in a Clinical Trial A retiree in Virginia (East Region, Humana Military) has a rare form of retinal degeneration. Standard TRICARE treatments are ineffective. They find an NEI clinical trial in Bethesda. The NEI covers the experimental surgery, while the retiree’s TRICARE Select plan covers the routine diagnostic bloodwork required before the procedure (subject to 2026 deductible and cost-shares).
### Scenario 2: New Treatment Adoption A family member is diagnosed with a specific type of corneal dystrophy. The NEI publishes a 2026 study proving a new laser treatment is superior to traditional surgery. Following this "proven" status, the Defense Health Agency updates the TRICARE Policy Manual to transition the procedure from "experimental" to "covered," allowing the member to receive treatment locally with a standard copay.
## Related terms * **Defense Health Agency (DHA):** The organization that manages TRICARE and decides which NEI-validated treatments become policy. * **National Institutes of Health (NIH):** The parent agency of the NEI, located in Bethesda, MD. * **Experimental/Investigational:** A TRICARE status for treatments that have not yet met the NEI's threshold for clinical proof. * **FEDVIP:** The Federal Employees Dental and Vision Insurance Program, which provides the actual vision insurance (glasses/contacts) most TRICARE retirees use. * **Standard of Care:** Medical treatments that are currently accepted by medical experts (like the NEI) as proper treatment for a certain disease.
## Sources * **National Eye Institute (NEI):** https://www.nei.nih.gov * **TRICARE.mil Vision Coverage:** https://www.tricare.mil/CoveredServices/Vision * **NIH Clinical Center:** https://clinicalcenter.nih.gov * **Health.mil (Defense Health Agency):** https://health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/TRICARE-Health-Plan